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ABSTRACT
The central importance of translational control by post-translational
modification has spurred major interest in regulatory pathways that
control translation. One such pathway uniquely adds hypusine to
eukaryotic initiation factor 5A (eIF5A), and thereby affects protein
synthesis and, subsequently, cellular proliferation through an
unknown mechanism. Using a novel conditional knockout mouse
model and a Caenorhabditis elegans knockout model, we found an
evolutionarily conserved role for the DOHH-mediated second step of
hypusine synthesis in early embryonic development. At the cellular
level, we observed reduced proliferation and induction of senescence
in 3T3 Dohh−/− cells as well as reduced capability for malignant
transformation. Furthermore, mass spectrometry showed that
deletion of DOHH results in an unexpected complete loss of hypusine
modification. Our results provide new biological insight into the
physiological roles of the second step of the hypusination of eIF5A.
Moreover, the conditional mouse model presented here provides a
powerful tool for manipulating hypusine modification in a temporal
and spatial manner, to analyse both how this unique modification
normally functions in vivo as well as how it contributes to different
pathological conditions.
KEY WORDS: Hypusine modification, Translational control, Cancer,
Mouse models
INTRODUCTION
The highly conserved and unique post-translational hypusine
modification of a single cellular protein, the eukaryotic initiation
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factor 5A (eIF5A), represents an essential mechanism in the control
of proliferation of eukaryotic cells (Cooper et al., 1982). This
modification leads to the activation of eIF5A and is mediated by
deoxyhypusine synthase (DHS), which catalyses the transfer of a 4-
aminobutyl moiety of spermidine to the ε-amino group of Lys50 to
form an intermediate residue, deoxyhypusine (Dhp50) (Park et al.,
1981). Subsequently, deoxyhypusine hydroxylase (DOHH) mediates
the formation of hypusine (Hyp50) by hydroxylation of the
deoxyhypusine residue (Abbruzzese et al., 1986). A fundamental but
yet unanswered question relates to whether there are functional
differences between the unmodified eIF5A(Lys50), the intermediate
deoxyhypusine-modified eIF5A(Dhp50) and the fully hypusine-
modified eIF5A(Hyp50).
Hypusine modification occurs in two isoforms of human and
rodent eIF5A. The eIF5A-1 isoform is expressed at high levels in all
tissues, although the eIF5A-2 isoform is detectable only in some
embryonic tissues, adult testis, central nervous system and cancer
tissue (Clement et al., 2003; He et al., 2011; Jenkins et al., 2001;
Zhu et al., 2011). Hypusine formation in eIF5A has been proposed
to promote various cellular processes that potentially regulate
proliferation, most notably mRNA translation (Henderson and
Hershey, 2011; Saini et al., 2009) and nucleocytoplasmic transport
of RNA (Lipowsky et al., 2000; Maier et al., 2010). Hypusine
modification has also been implicated in numerous pathological
conditions, including malignant transformation (Scuoppo et al.,
2012; Zender et al., 2008), diabetes (Maier et al., 2010) and HIV
infection (Bevec et al., 1996; Hauber et al., 2005). Although
hypusine modification of eIF5A is highly conserved and essential
for cell viability of all eukaryotes, its crucial cellular role in
mammals remains unknown.
eIF5A was originally proposed to be an initiation factor because
of its ability to stimulate methionyl-puromycin synthesis in cell-free
translation extracts (Benne et al., 1978; Kemper et al., 1976).
However, this has been questioned due to the lack of a significant
effect of eIF5A on global protein synthesis in yeast (Kang and
Hershey, 1994) or on the translation of native rabbit globin mRNA
(Schreier et al., 1977). Recent studies have concluded that eIF5A
functions primarily in translation elongation (Gregio et al., 2009;
Saini et al., 2009). However, others have argued that the role of
eIF5A in protein synthesis is likely to be confined to the formation
of the first peptide bond during translation initiation (Henderson and
Hershey, 2011). Given the modest effects on general protein
synthesis, it has also been suggested that eIF5A could actually be
important for the translation of a specific subset of mRNAs
encoding, for example, cell cycle regulators (Hanauske-Abel et al.,
1994; Kang and Hershey, 1994; Zuk and Jacobson, 1998).
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Encouraging reports in this direction have been described recently
for yeast eIF5A and for the bacterial orthologue, the elongation
factor P (EF-P). Like eIF5A, the activity of EF-P is regulated via a
post-translational modification. In contrast to eIF5A, EF-P is not
hypusinated, but lysinylated by YjeK and YjeA, and finally
hydroxylated by YfcM (Bailly and de Crécy-Lagard, 2010; Navarre
et al., 2010; Peil et al., 2012). Both eIF5A and EF-P have been
shown to be particularly crucial for the synthesis of proteins
containing consecutive prolines (Doerfel et al., 2013; Gutierrez et
al., 2013; Ude et al., 2013).
Temperature-sensitive Saccharomyces cerevisiae mutants revealed
that the loss of either eIF5A or DHS function is lethal in yeast (Park
et al., 1998; Sasaki et al., 1996; Schrader et al., 2006). Recently
published constitutive knockout mouse models for eIF5A and DHS
show embryonically lethal phenotypes, and thus support the vital
function of the hypusine modification for the development of
eukaryotic cells and organisms (Nishimura et al., 2012; Templin et
al., 2011). For the second step of hypusine synthesis, catalysed by
DOHH, the effect on growth and proliferation appears to be
organism and cell-type specific. In yeast, DOHH knockout causes
only a very mild growth phenotype (Park et al., 2006; Weir and
Yaffe, 2004), implying that the second step of hypusination is
dispensable for the essential function of eIF5A in this organism. In
contrast, disruption of DOHH in D. melanogaster is lethal early in
development (Patel et al., 2009), suggesting that the maturation of
eIF5A(Dhp50) to eIF5A(Hyp50), catalysed by DOHH activity,
might be crucial for the viability of higher eukaryotes. Thus, one can
hypothesize that fully hypusine-modified eIF5A(Hyp50) plays a
central role in multicellular organisms that eIF5A(Dhp50) cannot
fulfil. Using gene targeting of Dohh in mice and Caenorhabditis
elegans, we show that DOHH activity is crucial for mammalian
development, as well as for proliferation and oncogenic
transformation of a fibroblast cell line. Mass spectrometry analyses
of eIF5A after depletion of DOHH revealed that hydroxylation of
deoxyhypusine is essential for stabilization of hypusine. Moreover,
we show that loss of DOHH in mammalian cells affects protein
biosynthesis and provide strong evidence for a fundamentally
important role of fully hypusinated eIF5A in mammals. Moreover,
because our results constitute the first analysis of the role of DOHH
in mammals, they have significant implications for targeted
therapies aimed at inhibiting this enzyme.
RESULTS
Loss of Dohh causes lethality during embryonic mouse
development
To determine the molecular function of the second step of hypusine
modification in mammals, we generated a mouse strain enabling
conditional knockout of Dohh (B6.Dohhtm1bal). Inactivation of Dohh
was achieved by using the Cre/loxP approach to target exons 2-4,
which include both the Dohh start codon and three of the four His-
Glu motifs essential for DOHH function (Kim et al., 2006) (Fig.
1A). Southern blot analysis and genotyping PCR confirmed correct
recombination in embryonic stem cells (ESC; Fig. 1B) and accurate
Cre-mediated Dohh deletion, respectively (Fig. 1C). To determine
the specific role of eIF5A(Dhp50) in embryonic development, Dohh
null allele (Dohh+/−) mice were generated by using CMV-Cre-deleter
mice expressing Cre in early embryonic development (Schwenk et
al., 1995). Heterozygous knockout mice (Dohh+/−) appeared normal
with respect to genotype distribution. However, mating of Dohh+/−
mice produced no homozygous Dohh−/− offspring (Fig. 1D). The
observed Dohh−/+:Dohh+/+ ratio was almost 2:1, significantly
varying from the expected Mendelian distribution of 1:2:1 (χ2-
value=1.3×10−6) and indicating embryonic lethality of Dohh−/− mice.
Additionally, Dohh−/+ × Dohh−/+ litters were on average significantly
smaller than Dohh+/flox × Dohh+/flox litters (Fig. 1E). In order to
narrow down the exact time-point of lethality, we examined
blastocysts and embryos at 3.5 and 9.5 days after conception (E3.5
and E9.5), respectively. Analysis of E3.5 blastocysts showed a
normal Mendelian distribution of genotypes, including Dohh−/− (Fig.
1D), and normal morphology (Fig. 1F). Genotyping of E9.5
embryos yielded results similar to those of postnatal offspring.
However, implantation sites of significantly smaller size harbouring
extra-embryonic tissue with no traceable residual embryonic tissue
were found, indicating lethality before E9.5 (Fig. 1G). This indicates
that loss of both Dohh alleles causes embryonic lethality arising
after implantation into the uterus (E4.5) but well before E9.5.
Compared with the strong effects of homozygous loss of Dohh,
heterozygous mouse embryos survive gestation and are superficially
indistinguishable from wild-type animals after birth. Over a period
of about 50 days, we did not detect significant abnormalities, either
in body weight (Fig. 1H) or in tissue morphology. It is worth noting
that we observed a diffuse infiltration of the spleen with a
homogenous, probably lymphoid, cell population in three Dohh+/−
animals, which was not present in any of the wild-type control mice
RESEARCH ARTICLE Disease Models & Mechanisms (2014) doi:10.1242/dmm.014449
TRANSLATIONAL IMPACT
Clinical issue
Post-translational modification (PTM) of proteins is critical for the
regulation of a variety of cellular functions in normal and pathological
conditions. Hypusine modification of the eukaryotic initiation factor 5A
(eIF5A), a highly specific and conserved protein modification, has been
linked to cancer, diabetes and infectious diseases. Although it is known
that the PTM is an essential regulatory mechanism involved in eukaryotic
cell proliferation, the specific role of hypusine modification in mammals
has remained relatively elusive. Understanding the cellular function of
this PTM in multicellular organisms is likely to provide insight into its
pathological relevance in the context of disease. 
Results
This study aimed to determine the importance of the second enzymatic
step in hypusine modification in multicellular organisms. Using a gene
targeting approach, the authors generated a mouse model allowing
conditional knockout of deoxyhypusine hydroxylase (DOHH), the enzyme
that catalyzes the second step in hypusine synthesis. Inactivation of both
alleles of DOHH in this novel mouse model resulted in embryonic
lethality. Furthermore, the authors established that loss of the DOHH
homolog in C. elegans causes defects in early embryonic development.
Analysis of the mutant phenotype in a mouse cell line revealed that loss
of the enzyme leads to reduced cellular proliferation and a senescence-
like phenotype. Mutant cells also demonstrated a reduced capacity for
malignant transformation. Finally, application of mass spectrometry
showed that deletion of DOHH causes a complete loss of hypusine
modification.
Implications and future directions
This research established a novel mouse model that allows specific
inhibition of the hypusine modification. The authors’ analysis of this
model and validation in C. elegans provides new evidence that the
DOHH-mediated second enzymatic step of hypusine synthesis is
evolutionarily conserved and essential for development of higher
eukaryotes. At the cellular level, the authors show that this PTM is
required for proliferation of normal cells and affects the capacity of cells
to undergo malignant transformation, which has implications for the
relevance of hypusine modification in cancer. Importantly, this new
mouse model for the conditional inhibition of the hypusine modification
provides a tool to study the physiological and pathophysiological function
of the PTM. In the long term, this model could advance the development
of novel therapeutic approaches particularly in cancer and infectious
diseases. 
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(Fig. 1I). Because reports have linked hypusine modification to
lymphoma development (Scuoppo et al., 2012), we examined the
haematopoietic system (peripheral blood, bone marrow and spleen)
of Dohh+/− compared with Dohh+/+ mice in more detail. As depicted
in supplementary material Figs S1 and S2, no significant
haematological abnormalities appeared in young or adult Dohh+/−
animals compared with wild type.
dohh-1 is required for early embryonic development in 
C. elegans
Given the strong effects of a homozygous deletion of Dohh on early
murine embryonic development, we pursued an additional approach
to further characterize the role of DOHH in early development. C.
elegans is a powerful model system for studying the function of
genes during early embryonic development (Sönnichsen et al.,
2005). The C. elegans dohh-1 locus expresses a 33.2-kDa protein
that shows 53.6% homology to mouse DOHH (Fig. 2A,B). The
HEAT-repeats and iron-binding sites, both essential for enzyme
function, exhibit a particularly high degree of homology. To
determine the role of the DOHH homolog in C. elegans during
development, we used the dohh-1(gk398) allele that deletes 371 bp
of the dohh-1 coding sequence. We found that maternally rescued
homozygous dohh-1 mutants completed larval (L1 to young adults)
development normally, without any phenotypical abnormalities
compared with heterozygous or wild-type animals (Fig. 2F,G).
However, maternally rescued dohh-1 homozygous mutants produced
no progeny. Beginning from the one-cell stage, embryos exhibited
strong abnormalities with development of sometimes multinucleated
cells (Fig. 2D,E,H,J top). This resulted in accumulation of strongly
altered, enlarged embryos in the uterus (Fig. 2H,J top) compared
with heterozygous worms (Fig. 2I,J bottom). These data suggest that
loss of dohh-1 results in either a fertilization defect in the
965
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Fig. 1. Loss of both Dohh alleles elicits
lethality during early embryonic
development. (A) Strategy for deletion of
Dohh by introduction of loxP sites into
introns 1-2 and 4-5 of Dohh. (B) Southern
blot of ESC after recombination with the
targeting construct. A transgenic (tg) 14-kb
NdeI fragment is recognized after
successful recombination in four out of nine
clones. (C) Representative results for
genotyping PCR for all the different
genotypes. Primers are indicated in
supplementary material Table S2.
(D) Distribution of genotypes in litters of
Dohh+/− × Dohh+/− matings. Numbers in
parentheses indicate the number of
examined litters. (E) Comparison of
numbers of pups per litter in Dohh+/− ×
Dohh+/− against Dohh+/flox × Dohh+/flox
matings. Significance has been determined
using t-tests. (F) Representative blastocysts
showing normal phenotype for wild-type,
heterozygous and homozygous Dohh
genotypes (E3.5). (G) The upper panel
shows the uterus horn on E9.5 of a Dohh+/−
× Dohh+/− mating. Arrowheads indicate
implantation sites of smaller size than
expected containing no embryos. The lower
panel shows the uterine bead of a resorbed
embryo after dissection of the outer
muscular layers. (H) Body weight curves of
mice of the Dohh+/+ and Dohh+/− genotypes,
showing no growth difference between both
genotypes. (I) Morphological examination 
of the spleen of Dohh+/− mice revealed
diffuse infiltration compared with Dohh+/+
animals, probably with lymphoid cells.
Representative micrographs out of three
animals per genotype are shown.
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spermatheca or a defective cleavage process during blastocyst
development.
Loss of DOHH causes reduced proliferation and a
senescence-like phenotype in fibroblasts
To further examine possible mechanisms that lead to the observed
strong phenotype in vivo, we established an immortalized 3T3 cell line
based on mouse embryonic fibroblasts (MEFs) of floxed embryos,
allowing for the inducible homozygous knockout of Dohh.
Immortalized 3T3 cells were stably transfected with a retroviral
pMSCV CreEsr1 expression plasmid or a negative control plasmid
without the CreEsr1 insert. The extent of the 4-hydroxytamoxifen (4-
OHT)-induced Dohh knockout was confirmed on DNA, RNA and
protein levels (Fig. 3A-C). After knock out of Dohh, the cells showed
a decrease in proliferation compared with control cells (Fig. 3D) and
an increase in G2 phase of the cell cycle, but no overt cellular death
(supplementary material Fig. S3). The anti-proliferative effects were
less pronounced in unfloxed control cells (supplementary material Fig.
S4) and could be partially compensated by retroviral Dohh
overexpression (supplementary material Fig. S5). Of note, additional
incubation of 3T3 Dohhflox/flox; Crepos. cells with 4-OHT and the DHS-
inhibitor GC7 led to an even stronger reduction in cellular growth,
most probably indicating an additive effect of DHS and DOHH
inhibition on proliferation (supplementary material Fig. S6).
Interestingly, knockout cells started to become rounder and flatter and
increased their surface diameter by a factor of 5-10, showing a
granular appearance in light microscopic analysis. As this phenotype
strongly resembles cellular senescence, cells were stained for
RESEARCH ARTICLE Disease Models & Mechanisms (2014) doi:10.1242/dmm.014449
Fig. 2. Loss of dohh-1 function in C. elegans leads to early embryonic lethality. (A) Representation of the C. elegans dohh-1 locus and the gk398 deletion
allele. (B) C. elegans DOHH-1 protein contains 6 EZ-type HEAT repeat domains. (C-G) Differential interference contrast microscopy images (DIC) of dohh-1
homozygous mutant animals show normal larval development (F-G). Adult animals exhibit wild-type germ lines (C), but defective embryos (arrows in D,E,H). 
(I-J) DIC of heterozygous dohh-1(gk398)/mIn1[mIs14 dpy-10(e128)] II animals.
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senescence-associated β-galactosidase (SA-β-gal). Indeed, knockout
cells showed a significantly higher ratio of SA-β-gal-positive cells
compared with the empty vector control (Fig. 3E.F), suggesting that
proliferation of Dohh knockout cells is impaired by a senescent-like
cell cycle arrest.
To ascertain whether the DOHH deficiency led to reduced
hypusine modification of eIF5A(Dhp50), we examined the
isoelectric points (pI) of modified and unmodified eIF5A isoforms
using two-dimensional (2D) western blots, as described previously
(Dyshlovoy et al., 2012). 2D western blots of lysates from DOHH-
967
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Fig. 3. Fibroblasts show reduced proliferation, a senescence-like phenotype and reduced hypusine modification upon complete loss of DOHH
expression. (A) Genotypes of 4-OHT-induced and uninduced cells, as well as a Cre-negative control cell line revealed the genomic deletion of both Dohh
alleles in Dohhflox/flox; Crepos. 3T3 cells. Primers are indicated in supplementary material Table S2. (B) By using real-time RT-PCR, a decline of the Dohh
transcript was observed in Dohhflox/flox; Crepos. cells relative to Gapdh and a Cre-negative control cell line (Dohhflox/flox; Creneg). In parallel, expression of eIF5A
was upregulated at the RNA level, most likely to compensate for the loss of DOHH. (C) Western blot analysis of DOHH in 4-OHT-induced and uninduced cells,
as well as a Cre-negative control cell line revealed the reduction of DOHH protein expression in Dohhflox/flox; Crepos. 3T3 cells after deletion of Dohh compared
with Dohhflox/flox; Creneg cells. Tubulin served as an internal standard. (D) Growth inhibition of Dohhflox/flox; Crepos. fibroblasts after 4-OHT induction, relative to a
Dohhflox/flox; Creneg. control cell line. Level of significance was analysed using one-way ANOVA with Dunnett’s multiple comparison tests. (E) SA-β-Gal-positive
cells after 1 week of 4-OHT induction, compared with a CreEsr1-negative control cell line. Level of significance was analysed using two-way ANOVA with
Bonferroni post-tests. (F) Representative light microscopic images of cells of the experiments analysed in E, showing enlarged SA-β-Gal-positive cells after
knock out of Dohh. (G) 2D western blots against eIF5A and GAPDH of fibroblast lysates treated as indicated on the panel depict a shift of a proportion of eIF5A
from pH 5.2 (green arrow) to 5.1 (red arrow) after 4-OHT induction and a shift from pH 5.2 to 5.1 and 5.0 (yellow arrow), indicating a reduced hypusine
modification. (H) Network function and gene ontology analysis of differentially expressed genes in Affymetrix microarrays after deletion of Dohh by 4-OHT in
3T3 Dohhflox/flox; Crepos. cells versus 3T3 Dohhflox/flox; Creneg. control cells. (I) Quantititive RT-PCR for some differentially expressed genes identified in the
microarray analyses. qRT-PCR was performed in triplicates with Gapdh as a housekeeping control gene. ***P<0.001, **P<0.01.
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positive cells showed a single signal for eIF5A at a pI of 5.2,
whereas a second signal appeared at a pI of 5.1 in DOHH-deficient
cells, indicating the partial inhibition of hypusine modification
(Fig. 3G). Control experiments using the DHS-inhibitor GC7
revealed an almost complete inhibition of the hypusine modification,
marked by the appearance of a third, even more acidic, signal. To
identify molecular pathways potentially involved in observed
cellular effects, we performed a gene microarray analysis of 3T3
Dohhflox/flox; Crepos. cells after 4-OHT treatment compared with the
control. Our results showed that a great number of genes showed
altered expression levels after deletion of Dohh (supplementary
material Table S1). Among these 464 upregulated and 791
downregulated genes, gene ontology (GO) and network analysis
using Ingenuity software revealed that many were involved in
cellular development, cancer and proliferation control (Fig. 3H). We
confirmed modulation of expression after inhibition of hypusine
modification for some genes by quantitative RT-PCR (Fig. 3I).
Interestingly, we detected an upregulation of eIF5A2 as a
consequence of deletion of Dohh. Furthermore, these analyses
revealed a decreased expression of different members of the Wnt-
pathway (e.g. Fzd2) and a strong upregulation of Myc (Fig. 3I).
Hydroxylation of eIF5A by DOHH prevents reversibility of
the DHS-mediated reaction
In the next set of experiments, we used mass spectrometry (MS) to
characterize the effects of Dohh deletion on the modification of
eIF5A at the molecular level. To isolate modified and unmodified
eIF5A, we separated whole proteins lysates of 3T3 Dohhflox/flox;
Crepos. cells after 9 days of 4-OHT treatment using large-scale 2D
gel electrophoresis (Fig. 4A). We then picked two spots that,
according to our previous research, corresponded to the unmodified
(spot 1) and the modified eIF5A (spot 2), and digested both protein
spots using endopeptidase LysC (Dyshlovoy et al., 2012). This
enzyme provides the advantage of a hypusine-specific digest at
Lys50 of eIF5A. If Lys50 is unmodified, LysC is able to cleave
eIF5A on the carboxyl site of Lys50. In the presence of hypusine or
deoxyhypusine, this site is blocked for LysC (Klier et al., 1995). 
In this case, the digest revealed a peptide of 906 Da
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Fig. 4. Knock out of Dohh leads to loss of the entire hypusine modification. (A) Representative 2D-PAGE of Dohhflox/flox; Crepos. 3T3 cells after treatment
with 4-OHT and an enlarged region of the gel showing two spots for eIF5A at pH 5.2 and pH 5.1. (B) MS spectrum of eIF5A with an isoelectric point at 5.1
digested with LysC. Red frames highlight that neither the peptide for the deoxyhypusine-modified nor the peptide for hypusine-modified peptide appeared in the
spectrum. (C) MS spectrum of eIF5A with an isoelectric point at 5.2 digested with LysC. In comparison with the more acidic isoform, both modified peptides
(hypusine-modified and the deoxyhypusine-modified) are represented, with clear peaks at an m/z of 906.6248 and 922.6204, respectively. (D) Annotated y-
and b-fragments of MS/MS spectra of the 906.6248 peptide shows the deoxyhypusine-modified lysine at position 50 of eIF5A. (E) Annotated y- and b-
fragments of MS/MS spectra of the 922.6204 peptide shows the fully hypusine-modified eIF5A after hydroxylation by DOHH. D
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(TGKDeoxyhypusineHGHAK) for the deoxyhypusine-containing eIF5A
and a peptide of 922 Da (TGKHypusineHGHAK) for the fully
hypusinated protein, among others (Fig. 4C). In the presence of
unmodified lysine, neither the 906-Da peptide nor the 922-Da
peptide were detected (Fig. 4B). Further fragmentation clearly
identified Lys50 as the site of modification responsible for the 16-
Da mass difference between the 906-Da peptide (Fig. 4D) and the
922-Da peptide (Fig. 4E). The discrepancy of 16 Da is consistent
with a loss of a hydroxyl group, indicating that after Dohh deletion,
spot 2 consists of both the deoxyhypusine- and the hypusine-
modified eIF5A. It is important to note that neither deoxyhypusine
nor hypusine could be detected in spot 1 (Fig. 4B). Therefore, our
data indicate that depletion of DOHH resulted in inhibition of
hydroxylation and a subsequent loss of deoxyhypusine, leading to
the appearance of spot 1. These observations suggest that the
addition of a hydroxyl group to deoxyhypusine prevents the
reversibility of the DHS reaction and stabilizes hypusine.
Loss of Dohh affects H-RasV12- and Myc-mediated
transformation
It has previously been shown that eIF5A and the DHS-mediated
hypusine modification are linked to cancer (Guan et al., 2001;
Preukschas et al., 2012; Tang et al., 2010; Zender et al., 2008).
However, in the absence of genetic tools, it has previously not been
possible to examine the impact of the second step of hypusine
modification on malignant transformation. We therefore examined
the effect of Dohh disruption on malignant transformation of 3T3
cells, using stable overexpression of oncogenic c-Myc or the
combination of H-RasV12 and c-Myc in Dohhflox/flox; CreEsr1pos. 3T3
cells, which represent a widely used in vitro model to study effects
on the malignant transformation of cells (Falcone et al., 1987). After
induction of Dohh knockout in the presence of c-Myc or H-RasV12
and c-Myc, cell proliferation decreased (Fig. 5A,B) and senescence
induction increased (Fig. 5C,D), concordant with a reduction in
hypusine-containing eIF5A in 2D western blots (Fig. 5E). This
outcome was observed in partially transformed cells expressing c-
Myc (Falcone et al., 1987), as well as fully transformed cells
expressing H-RasV12 and c-Myc. Interestingly, in an anchor-
independent growth experiment, Dohh−/− cells formed fewer
transformed colonies. The number of visible colonies was reduced
by ~80% compared with control cells (Fig. 5F), consisting mainly
of small colonies (Fig. 5G). Treatment with 15 μM GC7, despite
having a comparable impact on hypusine-containing eIF5A in 2D
western blots (data not shown), had a less-pronounced effect on cell
proliferation, induction of senescence and growth in soft agar. These
results establish a relationship between DOHH-mediated hypusine
modification and malignant transformation of mammalian cells.
Loss of DOHH activity affects protein synthesis
eIF5A has been implicated in protein synthesis, but whether DOHH-
mediated hydroxylation of hypusine is crucial for its role in this
process in mammals has not yet been previously investigated. To
address this question, we first performed metabolic labelling
experiments to monitor new protein synthesis in the presence or
absence of DOHH. We labelled newly synthesized proteins with
non-radioactive methionine analogues and detected these using bio-
orthogonal (‘Click’) chemistry. This revealed a reduction in protein
synthesis by roughly 50%, specifically in Dohh knockout cells (Fig.
6A). To gain insight into the mechanism, we used polysome
profiling (Fig. 6B-G). As shown in Fig. 6B,C, a comparison of
tamoxifen-induced 3T3-Dohhflox/flox; CreEsr1pos. Dohh knockout
cells and control cells revealed a decrease in the
polysome/monosome (P/M) ratio in cells lacking DOHH, the
hallmark of a translation initiation defect. A decreased P/M ratio
relative to control cells was still observed even when the elongation
inhibitor cycloheximide was omitted, indicating that cycloheximide
treatment was not masking an elongation defect. Taken together, our
metabolic labelling and polysome results indicate that both protein
synthesis and translation initiation are compromised in mammalian
cells lacking DOHH. Given the strong evidence from yeast that
eIF5A plays a role in elongation, we presume that the apparent effect
on translation initiation is likely to be an indirect effect (see
Discussion). Treating cells with the DHS inhibitor GC7 also led to
decreased P/M ratios (Fig. 6D,E), consistent with previous reports
(Landau et al., 2010).
In principle, the effect on translation initiation observed with
DOHH depletion could be a cause or consequence of altered cellular
proliferation. To distinguish between these possibilities, we treated
cells with doxorubicin, a proliferation inhibitor with no known direct
effects on the mRNA translational machinery. As shown in
Fig. 6F,G, polysome profiles from doxorubicin-treated cells revealed
precisely the opposite effect to DOHH depletion and GC7 treatment.
These results demonstrate that altered cellular proliferation does not
necessarily mimic the effects of loss of DOHH function on protein
synthesis in mammals.
DISCUSSION
Hypusine modification has been implicated in the regulation of
important cellular processes including translation, RNA metabolism,
proliferation and apoptosis, in both health and certain diseases.
However, the functional consequence of inhibiting the second step
of this modification has not been extensively explored before. This
study combines genetics and functional data from C. elegans with a
new knockout mouse model to demonstrate that the DOHH-
mediated step of hypusine modification has a pivotal function in
murine and nematode development, in cell proliferation, malignant
transformation and translation. Although studies in prokaryotes
suggest that the polyamine network is functionally interchangeable
and loss of an important enzyme can be mitigated by substitution
(Tholl et al., 1998), the situation in eukaryotes seems to be more
complex. Based on our results and recent studies on eIF5A and DHS
(Enard et al., 2009; Hanazawa et al., 2004; Nishimura et al., 2012;
Templin et al., 2011), it is reasonable to assume that in multicellular
eukaryotes the elimination of any one of the members of the
hypusine system is fatal regarding organism development. In this
regard, it is important to note that gene inactivation studies on Dohh
have revealed a mild effect on the phenotype in yeast (Park et al.,
2006) and a more pronounced lethal phenotype in Drosophila (Patel
et al., 2009). In line with the latter observation, we observed a strong
effect of Dohh deletion on early embryonic development in C.
elegans and mice. We also observed Dohh depletion to cause a
strong alteration of the transcriptional activity of more than 1000
genes in 3T3 cells. How DOHH regulates gene transcription remains
speculative, yet we assume that loss of DOHH affects eIF5A-
dependent translation of proline-rich mRNAs comprising a variety
of transcriptional regulators, therefore indirectly leading to broad
changes in gene expression. It is worth noting that a significant
subset of those genes are involved in developmental processes, thus
explaining the observed developmental phenotypes. Our findings
support the hypothesis that the second step of hypusine modification
is particularly important for multicellular eukaryotes and expand the
knowledge on the vital function of DOHH-mediated conversion of
eIF5A(Dhp50) to eIF5A(Hyp50) in nematodes and mammals. These
species-specific phenotypes can be due to different functions of
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eIF5A(Dhp50) and eIF5A(Hyp50) in single- versus multicellular
organisms and might be based on conformational differences
between eIF5A(Dhp50) and eIF5A(Hyp50) that lead to interactions
with pathways specific to phylogenetically higher organisms.
Interestingly, our studies in C. elegans revealed that the loss of
dohh-1 mirrors, at least partially, the previously observed effects of
the deletion of the eIF5A-1 homologue iff-2 on early embryonic
development (Hanazawa et al., 2004). In analogy to this study, we
detected strong effects on early embryonic development that might
be due to effects on fertilization or on the cleavage process. It is
worth noting that we did not observe the same phenotypical
alterations in the germ line that were described for the iff-1 isoform
(Hanazawa et al., 2004). These observations suggest that, in C.
elegans, the second step of hypusine modification is probably
crucial for the function of iff-2 but not for iff-1 during embryonic
development. Co-deletion of the iff-1 or iff-2 isoforms together with
dohh-1 would provide an appropriate strategy to further address that
question.
A long-standing question with respect to hypusine modification is
whether the hydroxylation of deoxyhypusine by DOHH is crucial
RESEARCH ARTICLE Disease Models & Mechanisms (2014) doi:10.1242/dmm.014449
Fig. 5. DOHH activity affects malignant
transformation of 3T3 fibroblasts. (A) Population
doublings of Dohhflox/flox; Crepos. or Dohhflox/flox; Creneg.
3T3 cells after treatment with 4-OHT or GC7, relative
to untreated control cells. The 3T3 cells were
retrovirally transduced with c-Myc. (B) Population
doublings of Dohhflox/flox; Crepos. or Dohhflox/flox; Creneg.
3T3 cells after treatment with 4-OHT or GC7, relative
to untreated control cells. Cells were transformed by
subsequent retroviral transduction with c-Myc and 
H-RasV12. (C,D) Quantification of senescence by SA-β-
Gal assay in cells described in A and B after one week
of 4-OHT or GC-7 treatment. (E) 2D western blots
against eIF5A1 of H-RasV12 and c-Myc transformed
Dohhflox/flox; Crepos. cells treated with 4-OHT or GC7 or
with both substances. (F) Number of colonies grown in
soft agar after 9 days of pre-treatment with 4-OHT/
GC7 in c-Myc and H-RasV12 transformed Dohhflox/flox;
Crepos. or Dohhflox/flox; Creneg. cells. GC7 was
furthermore added to the top agar for the 18 days of
incubation, whereas no extra 4-OHT was applied.
(G) Representative photographs (left) and light
microscopic images (right) of crystal violet stained and
unstained colonies grown in soft agar of cells
described in F. Level of significance was determined
for all experiments using t-tests (***P<0.001, **P<0.01,
*P<0.05). All analyses were performed at least in
triplicate.
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for the stability of the final hypusine residue. Former in vitro studies
have suggested that the hydroxyl residue prevents the reverse
reaction of DHS, which is the rate-limiting reaction in hypusine
modification (Wolff et al., 2007). Therefore, one important result of
our study showed that deletion of Dohh results in an expected loss
of the hydroxyl residue and in a surprising loss of the
deoxyhypusine group on Lys50, leading to an accumulation of
unmodified precursor eIF5A. These findings strongly suggest that,
at least in mice, the Dohh deletion acts through an accumulation of
both deoxyhypusine-modified and unmodified eIF5A. Therefore, the
observed developmental and cellular defects in mice and worms can
be based on an excess of intermediate or native eIF5A. As yeast
cells are capable of surviving without DOHH and accumulating
deoxyhypusine (Park et al., 2006), the physiological cellular
conditions of single cell eukaryotes do not seem to provide an
optimal environment for the reverse reaction of DHS. In yeast cells,
accumulated deoxyhypusine-modified eIF5A might be sufficient to
fulfil vital functions normally conducted by the hypusine-modified
eIF5A, resulting in survival of Dohh-deleted strains. On-going
studies using a conditional knockout mouse model for Dhs will help
us to more clearly differentiate the impacts of DOHH and DHS
function in higher eukaryotes.
Altered translational regulation is increasingly recognized to be
an important factor in malignant transformation (Ruggero, 2013;
Silvera et al., 2010). In this context, we and others have linked the
hypusine modification system to various types of cancer
(Preukschas et al., 2012; Scuoppo et al., 2012). In most of the
studies, eIF5A is overexpressed in tumours and has been linked to
patient prognosis in some types of cancer (Caraglia et al., 2013),
although the impact of fully hypusine-modified eIF5A in cancer
biology is still unknown. As inhibition of hypusine modification has
been proposed to be a target for therapy of various types of cancer
(Balabanov et al., 2007), we decided to test whether the specific
deletion of Dohh affects the process of malignant transformation in
971
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Fig. 6. Dohh deletion impairs protein synthesis.
(A) Dohh depletion causes a reduction in the rate of
protein synthesis. Cells were treated for 9 days with
tamoxifen or were mock-treated as indicated. Newly
synthesized proteins were labelled using bio-
orthogonal (‘Click’) chemistry. Label incorporated into
newly synthesized proteins was normalized to total
protein content to determine the relative rate of protein
synthesis. Note the strong reduction in label
incorporation in cells treated with CHX, which
demonstrates that labelling depends on new protein
synthesis and indicates the large dynamic range of
the assay. (B) Polysome profile comparison of 3T3
cells with tamoxifen-inducible Cre removal of 
DOHH (Dohhflox/flox; Crepos.) with those without
(Dohhflox/flox; Creneg.). Uninduced cells (CHX) show
similar polysome profiles and P/M ratios. After
removal of DOHH (Dohhflox/flox; Crepos.: CHX/4-OHT
and 4-OHT), profiles showed a clear increase in 80S,
coupled with a mild reduction in polysomes, consistent
with a translation initiation defect. (C) Ratios of P/M
Crepos. to P/M Creneg. for each condition described in
A. Tamoxifen-induced cells show significantly reduced
ratios in comparison with uninduced cells (CHX to
CHX/4-OHT, P=0.03; CHX to 4-OHT, P=0.033; n=3;
one-tailed, type 3 t-test). (D) Polysome profiles of 3T3
cells treated with GC7 to inhibit DHS activity. Profiles
generated by GC7 treatment phenocopy those
produced by removal of Dohh, but the effect is
stronger. (E) Quantification of P/M ratios shows a
significant difference between control and GC7-
treated 3T3 cells (P=0.026; n=3; one-tailed, type 3 
t-test). (F,G) Polysome profile and P/M ratio
quantification for 3T3 cells treated with doxorubicin,
an inhibitor of cell growth that does not directly
interfere with translation. Note the absence of a Dohh-
like initiation defect in doxorubicin-treated cells. Data
are displayed as mean ± s.e.m. P-values were
determined using Student’s unpaired t-test (**P<0.01,
***P<0.001).
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cell culture. In this regard, our data support the assumption that the
final step of hypusine modification of eIF5A is a crucial regulator
of different characteristics of cancer cells. In line with other studies,
our results suggest that inhibition of hypusine modification
negatively regulates the proliferation of oncogene-transformed cells
and reduces their capacity for anchor-independent growth. Post-
translational modifications of other translational regulators have
already been linked to the process of malignant transformation
(Ruggero, 2013; Silvera et al., 2010), such as the regulation of
phosphorylation of eIF2α, eIF4E and the 4E-binding proteins
(Donzé et al., 1995; Furic et al., 2010; Wendel et al., 2007).
Inhibition of translation has also been shown to increase the
susceptibility of tumour cells to chemotherapy or targeted therapies
(Balabanov et al., 2007; Bordeleau et al., 2008; Robert et al., 2009).
Accordingly, the inhibition of hypusine-dependent translation of
specific mRNA might have the potential to serve as a target for
novel therapeutic intervention approaches in oncology. Due to the
observed effects of Dohh depletion on normal cells in vitro and in
vivo, future studies are required to identify hypusine-dependent
pathways specific for cancer cells. In this context, it is worth
highlighting a recent study that links the function of hypusine
modification as a tumour suppressor in lymphoma development
(Scuoppo et al., 2012). Here, Scuoppo and co-workers demonstrated
that the shRNA-mediated reduction of eIF5A expression, or
decreased hypusine modification through knockdown of DHS,
augmented lymphoma development in the Eμ-myc mouse model.
These results pointed out that the hypusine modification system has
pleiotropic effects and can act either as promoter or suppressor of
malignant transformation, depending on the cellular environment.
Interestingly, we observed an upregulation of eIF5A1 and eIF5A2
transcripts after deletion of Dohh (Fig. 3B,I), as was found in a
recent Drosophila melanogaster study (Patel et al., 2009). However,
the eIF5A1 protein expression level seems to be unaffected in semi-
quantitative western blot analysis (supplementary material Fig. S7).
Thus it seems that, at least on transcript level, a conserved positive
feedback loop exists in eukaryotic cells, which might be activated
to compensate for the decreased translational activity due to a loss
of hypusine modification. In this respect it is important to note that
we also observed a transcriptional upregulation of c-Myc. Because
it has been shown that c-Myc directly regulates several components
of the protein biosynthesis machinery, one can speculate that
overexpression of c-Myc represents a further mechanism to
compensate for reduced protein biosynthesis after the inhibition of
hypusine modification (Barna et al., 2008; Grewal et al., 2005; van
Riggelen et al., 2010). Interestingly, n-Myc controls spermidine
synthesis via the ornithine decarboxylase (ODC) and ODC-activity
antizyme (ODC-AZ), which consequently controls the spermidine
supply for eIF5A (Geerts et al., 2010). Those findings, together with
the observation that eIF5A gene expression is also subject to c-Myc
regulation, might further support this notion (Coller et al., 2000).
We observed reduced protein synthesis and altered polysome
profiles in cells lacking DOHH (Fig. 6A-C). An apparent effect on
initiation was surprising because there is significant evidence from
yeast for a primary role for hypusinated eIF5A in translation
elongation (Saini et al., 2009) and knockdown of both eIF5A or
DOHH in Drosophila cells led to polysome accumulation, consistent
with an elongation defect (Patel et al., 2009). It was recently
demonstrated in the lower eukaryote Saccharomyces that eIF5A
particularly promotes the translation of polyproline regions
(Gutierrez et al., 2013). This finding is in agreement with the
reported activity of the eIF5A orthologue EF-P in bacteria (Doerfel
et al., 2013; Ude et al., 2013). Thus, in our study using higher
multicellular eukaryotes it is intriguing that loss of hypusine
modification appears to affect initiation rather than elongation.
However, the experiments presented here cannot distinguish
between direct and indirect effects. In this context, it should be noted
that eIF5A has also been reported to exert secondary activities in
addition to promoting translation. In particular, eIF5A itself has
RNA-binding properties (Xu and Chen, 2001) and at least two
distinct cellular transcripts; the mRNAs encoding CD83 and iNOS,
have been shown to be subject to eIF5A-dependent
nucleocytoplasmic transport in mammalian cells (Kruse et al., 2000;
Maier et al., 2010). Interestingly, although both transcripts are
targets of eIF5A regulation, they do not encode typical polyproline
stretches (three or more consecutive proline residues). It is therefore
conceivable that, during evolution, eIF5A gained activities in
addition to its primary role in translation elongation, such as the
promotion of cytoplasmic accumulation of specific transcripts
(Hauber, 2010). It is evident that such an activity would result in
indirect effects on translation initiation, particularly in higher
multicellular eukaryotes.
Another possible interpretation of our data is that loss of either
DOHH or DHS function in mammals results in reduced translation
elongation rates that lead to reduced levels of the proteins required
for initiation, most likely containing polyproline regions (e.g. eIF-
4E and eIF-5). Alternatively, inhibition of hypusine modification
might perturb cellular carbon metabolism and thereby indirectly
inhibit translation initiation (Castelli et al., 2011).
Of note, the observed in vitro effects in immortalized 3T3 cells
were less pronounced than in the strong embryonic lethal phenotype.
This might be due to activation of certain cellular pathways during
the process of immortalization, rendering those cells less susceptible
to a loss of DOHH. Therefore, further studies analysing the
consequences of Dohh deletion in adult mice and primary non-
immortalized cells harvested from different tissue (e.g.
haematopoietic system and brain) need to be performed to elucidate
the physiological functions of DOHH.
In conclusion, we have demonstrated that DOHH is crucial for
early embryonic development of mice and C. elegans. Our studies
suggest that inhibition of the final step of hypusine modification
results in reduced efficiency of protein synthesis and establish this
enzymatic reaction as essential for the cellular function of eIF5A and
for the viability of mammalian cells. Furthermore, our work
supports the hypothesis that the functional specificity of the highly
conserved hypusine modification pathway phylogenetically evolved
to an essential pathway from yeast to mammals.
MATERIALS AND METHODS
Animal studies
All animal experimental procedures were approved by the responsible
Hamburg state authority according to German animal protection law.
Cloning of targeting vector
The vector for targeting murine Dohh was cloned using the BAC Subcloning
Kit as well as the Quick & Easy Conditional Knockout Kits (Cre/loxP and
Flp/FRT, respectively, all from Gene Bridges, Heidelberg, Germany). The
oligonucleotides used for PCR amplification are listed in supplementary
material Table S2.
Generation of conditional knockout mice
The targeting construct was linearized by SalI (Thermo Fisher Scientific,
Waltham, MA) digestion and electroporated into R1 ES cells (250 V, max.
500 μF, 5.5-6.5 millisecond pulse length) (Nagy et al., 1993). After 9 days
of G418 selection, clones were separated and expanded into four 96-well
culture plates, two of which were frozen for later expansion of positive
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clones. The two other replicas were used for genomic DNA isolation, which
was subsequently digested using NdeI (Thermo Fisher Scientific) and
analysed by Southern blot. Positive clones were thawed, injected into E3.5
blastocysts of C57BL/6J mice and transferred into the uterine horns of foster
mothers. Male chimeric offspring were mated to C57BL/6 females and the
resulting offspring analysed for transmission of the targeted allele (N1
generation). Transgene-positive male offspring were mated to Flp-deleter in
order to remove the selection cassette and subsequently backcrossed to the
C57BL/6 background over 10 generations (N10) (Rodríguez et al., 2000). To
enable an early embryonic knockout of Dohh, mice of the B6.C-Tg(CMV-
cre)1Cgn/J strain (Schwenk et al., 1995) were mated to mice of the
Dohh+/flox genotype. Mice of the resulting Dohh+/− genotype were further
mated to individuals of the same phenotype.
Genotyping using genomic DNA from tail clippings, embryos or
culture cells
Samples were digested overnight at 55°C using Proteinase K (Thermo
Fisher Scientific, Waltham, MA) according to manufacturer’s instructions.
PCR analyses of genomic DNA were performed using 2 μl of lysate in a
total volume of 20 μl. The primer sequences are listed in supplementary
material Table S2.
C. elegans strains and DIC microscopy
All strains were maintained and raised at 20°C on NGM agar seeded with
Escherichia coli OP50 (Brenner, 1974). The following mutation was used
in this study: dohh-1(gk398)/mIn1[mIs14 dpy-10(e128)] II. Nematode
strains used in this work were provided by the Caenorhabditis Genetics
Center, which is funded by the NIH National Center for Research Resources
(NCRR). For microscopic evaluation, worms were placed on 3% agarose
pads and anaesthetized in 10 μl M9 containing 5 mM levamisole (Sigma-
Aldrich, St Louis, MO) and mounted under a coverslip for observation using
a Leica DM-RA microscope equipped with DIC (Nomarski) optics.
Cell culture
Mouse embryonic fibroblasts (MEFs) were isolated from Dohh+/flox ×
Dohh+/flox matings as described (Sun et al., 2007). Using the 3T3 protocol
(Todaro et al., 1963), a Dohhflox/flox and a Dohh+/+ cell line were generated. The
cells were cultured in DMEM (all cell culture media and additives from
Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum, 50
U/ml penicillin, 50 μg/ml streptomycin, 25 μM β-mercaptoethanol, and 4 mM
L-glutamine (37°C, 5% CO2, humidified atmosphere). 106 cells were seeded
on a 10-cm culture dish, maintained at subconfluence and treated with 100 nM
4-OHT (Sigma-Aldrich, St Louis, MO) or 15 μM GC7 (Biosearch Tech.,
Novato, CA) as indicated in the figures. Cell number and viability were
assessed using a ViCell cell counter (Beckman Coulter, Brea, CA).
Cell cycle analysis
Cell cycle analysis by propidium iodide staining was performed as described
(Riccardi and Nicoletti, 2006), followed by flow cytometric analysis
(FACSCalibur, BD, Franklin Lakes, NJ). 
Proliferation of 3T3 Dohhflox/flox; Crepos. cells compared with 3T3
Dohhflox/flox; Creneg. cells
Cells were cultured as described above. Both cell lines (3T3 Dohhflox/flox;
Crepos. cells and 3T3 Dohhflox/flox; Creneg. cells) were seeded and treated with
100 nM 4-OHT for 48 hours. At 96 hours after removal of 4-OHT, cells
were seeded at a concentration of 2.5×105 cells/10 ml on a 10-cm dish and
counted again 96 hours later using trypan blue exclusion assay. All
experiments were performed in triplicate. 
Effect of combination of GC7 and 4-OHT on proliferation of 3T3
Dohhflox/flox; Crepos. cells
Cells were cultured as described above. 3T3 Dohhflox/flox; Crepos. cells were
treated with 100 nM 4-OHT or solvent for 7 days. Afterwards, 4-OHT was
removed and cells were seeded at a concentration of 2.5×105 cells/10 ml on
a 10-cm dish, treated with 50 μM GC7 and counted 48 hours later using
trypan blue exclusion assay. All experiments were performed in triplicate. 
Rescue of Dohh-deleted cells by retroviral overexpression of
DOHH
Murine (mRNA) Dohh was PCR-amplified using cDNA purified from
NIH3T3 cells using Phu polymerase (Thermo Fisher Scientific, Waltham,
MA). The primer sequences are listed in supplementary material Table S2.
The 3′-primer was designed to include an additional FLAG-Tag sequence
before the stop codon. Furthermore, a point mutant coding for an inactive
Dohh-E57A (Dohhmut) mutant (Kang et al., 2007) was generated using the
Phusion site-directed mutagenesis kit (Finnzymes, Vantaa, FIN). Inserts and
the pBabe-hygro plasmid (Addgene number 1765) were digested with
EcoRI and BamHI restriction enzymes (FastDigest, Thermo Fisher
Scientific, Waltham, MA) and ligated using T4 DNA ligase (all according
to the manufacturer’s instructions). Ligations were transformed into DH5α,
ampicillin-selected overnight and verified by sequencing. Subsequent
retroviral transduction of either pBabe-hygro, pBabe-Dohh-hygro or pBabe-
Dohh-K57A-hygro plasmids into 3T3 Dohhflox/flox; Crepos. cells were
performed as described below. Afterwards, stable transduced cells were
selected using hygromycin. In order to measure proliferation rate, 3T3
Dohhflox/flox; Crepos. Dohh-hygro, 3T3 Dohhflox/flox; Crepos. Dohh-E57A-hygro
or 3T3 Dohhflox/flox; Crepos. empty-hygro cells were preincubated with 100
nM 4-OHT for 7 days to knock out Dohh. Afterwards, cells were seeded at
a concentration of 2.5×105 cells/10 ml on a 10-cm culture dish and counted
96 hours later using trypan blue exclusion assay. All experiments were
performed in triplicate. 
Cloning of Cre expression plasmid
Tamoxifen-inducible Cre recombinase was PCR-amplified using genomic
DNA purified from tail biopsies of the CAG-CreESR1 mouse strain using
Phu polymerase (Thermo Fisher Scientific, Waltham, MA). The primer
sequences are listed in supplementary material Table S2. Inserts and the
pMSCV puro plasmid were digested with the appropriate FastDigest
restriction enzymes (Thermo Fisher Scientific, Waltham, MA) and ligated
using T4 DNA ligase (all according to manufacturer’s instructions).
Ligations were transformed into DH5α, ampicillin-selected overnight and
verified by sequencing.
Retroviral transduction
Ecotropic retroviruses for the transduction of Dohhflox/flox cells were obtained
by transient calcium-phosphate-mediated transfection of the retroviral
vectors into the packaging cell line Phoenix eco (ATCC, Wesel, Germany).
Dohhflox/flox cells were transduced by adding the filtered, retrovirus-
containing supernatant and selected with puromycin as described previously
(Balabanov et al., 2011).
Microarray and real-time qRT-PCR
RNA from 4-OHT-induced (9 days; 100 nM) 3T3 Dohhflox/flox; Crepos. and
3T3 Dohhflox/flox; Creneg. cells was isolated using TriFast (Peqlab, Erlangen,
Germany) according to manufacturer’s instructions. cDNA was prepared by
reverse transcription of 1 μg total RNA using oligo(dT) primers and M-
MuLV reverse transcriptase (Thermo Fisher Scientific). Real-time RT-PCR
was performed using the DyNAmo Flash SYBR Green qPCR Kit (Thermo
Fisher Scientific) and QuantiTect Primer Mixes for murine Gapdh, Dohh,
eIF5A2, FZD2, Gremlin-1 and c-Myc (Qiagen, Hilden, Germany) in an
Mx3000 real-time thermocycler (Agilent, Santa Clara, CA). All samples
were measured in triplicate and normalized against Gapdh as reference gene
using the 2–ΔΔC(t) method (Livak and Schmittgen, 2001). The microarray
experiments were performed using Affymetrix mouse genome GeneChips
430 2.0 (Affymetrix, Santa Clara, CA) according to the manufacturer’s
protocol starting with 100 ng of total RNA for first strand synthesis. The
preparation was performed according to the One Cycle Protocol using the
GeneChip 3′ IVT Express Kit from Affymetrix. The arrays were incubated
for 16 hours in the Affymetrix Hybridization Oven 640 at 45°C. Washing
and staining steps were performed in the Affymetrix Fluidics Station 450
(Command Console 3.0). After washing and staining, the arrays were
scanned using the Affymetrix GeneChip Scanner 3000 7G, background
corrected and normalized with Affymetrix software (Expression console
using RMA). To identify genes that were positively or negatively regulated,
we used the TMeV software (4.7.4, www.tm4.org) for hierarchical clustering
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and t-tests (Saeed et al., 2006). A signal-log-ratio of ±0.8 and a P-value of
0.05 were used as cut-off values to determine gene lists for further
enrichment analysis. Following differential gene expression analysis, we
used the obtained lists of regulated genes to perform gene set enrichment
and network analysis with Ingenuity Pathway Analysis software (IPA;
Ingenuity Systems, Qiagen, Hilden, Germany).
Senescence-associated β-galactosidase activity
Senescence-associated β-galactosidase activity (SA-β-gal) activity was
assessed in cells fixed with 0.25% glutaraldehyde and 2%
paraformaldehyde. Cells were incubated at 37°C with a 5-bromo-4-chloro-
3-indolyl P3-D-galactoside (X-Gal) staining solution dissolved in PBS
containing 1 mM MgCl2, pH 5.5 as described (Braig et al., 2005). Per
sample, at least 300 randomly selected cells were counted and the number
of positive cells was divided by the total number of counted cells.
Two-dimensional polyacrylamide gel electrophoresis and
western blotting
Samples were applied to immobilized pH gradient (IPG) strips (pH 4-7 NL,
24 cm, from GE Healthcare, Munich, Germany) by in-gel rehydration. Per
gel, a total amount of 500 μg protein was filled to a volume of 450 μl with
rehydration buffer (8 M urea, 2 M thiourea, 2% CHAPS, 15 mM
dithiothreitol and 0.5% IPG buffer pH 3-10 NL, from GE Healthcare,
Munich, Germany). After rehydration overnight, isoelectric focusing (IEF)
and 2D-PAGE were carried out as described previously (Junker et al., 2011). 
Western blotting was carried out as described (Dyshlovoy et al., 2012).
Refer to supplementary material Table S3 for a list of primary and secondary
antibodies used in this study.
Protein identification by mass spectrometry
Protein spots of interest were excised from the gel manually, followed by an
in-gel digest with LysC (200 ng per gel spot) as described previously
(Dyshlovoy et al., 2012). For identification of the protein eIF5A and its post-
translational modification of lysine to hypusine via the intermediate
deoxyhypusine, we performed the measurements on the 4800 MALDI-
ToF/ToFTM Analyzer. The spectra were recorded in reflector mode in a mass
range from 450 to 1600 Da, with a focus mass of 700 Da, and in a mass range
from 875 to 4000 Da, with a focus mass of 2000 Da. The instrument was
calibrated with an external calibration using matrix dimers at m/z 379.0930
and des-Arg1-Bradykinin at m/z 904.4681 for the mass range 450-1,600 or
using the Mass Standards Kit for Calibration of AB SCIEX TOF/TOF™
Instruments as default calibration. MALDI-MS/MS analysis was performed
for m/z 906 and m/z 922. The MS and MS/MS spectra were annotated using
Data Explorer Software version 4.9 (build 115). Peak detection was carried
out with following parameters: valley to baseline; % centroid 50; signal-to-
noise threshold 3; noise window width (m/z) 250. The fragmentation was
proofed by an implemented ion fragmentation calculator with mass tolerance
of 0.8 m/z and use of monoisotopic masses. A database search of MS
measurements was performed online at http://www.matrixscience.com. Peak
lists were compared using the SwissProt 2012_08 database mouse taxonomy.
Peptide mixtures that yielded a Mowse score of 55 for database results were
regarded as positive identification.
Soft agar assay
Soft agar assays were performed as described recently (Ummanni et al.,
2011). In brief, 5×103 Dohhflox/flox cells treated with either 4-OHT or GC7
were resuspended in 0.35% agar in complete medium and poured over a
solidified layer of 0.5% agar. In the case of GC7 treatment, the drug was
added to the top agar. The cells were supplied by weekly addition of several
drops of fresh medium. After 2-3 weeks of incubation at 37°C, foci were
photographed, stained with 0.5% crystal violet and counted.
Morphological analysis of mouse tissue
Mice were transcardially perfused with a mixture of 4% paraformaldehyde
and 1% glutaraldehyde in 0.1 M phosphate buffer at pH 7.4. Sections (100-
μm thick) from spleen were cut with a Vibratom (Leica VT 1000S). The
sections were rinsed three times in 0.1 M sodium cacodylate buffer (pH 7.2-
7.4) and osmicated using 1% osmium tetroxide in cacodylate buffer.
Following osmication, the sections were dehydrated using ascending ethyl
alcohol concentration steps, followed by two rinses in propylene oxide.
Infiltration of the embedding medium was performed by immersing the
pieces in a 1:1 mixture of propylene oxide and Epon and finally in neat
Epon and hardened at 60°C. Semi-thin sections (0.5 μm) were prepared for
light microscopy, mounted on glass slides and stained for 1 minute with 1%
Toluidine Blue.
Characterization of peripheral blood, bone marrow and spleen
Young (2 months old) and old (ten months old) wild-type and heterozygous
Dohh+/– mice were euthanized by CO2 inhalation in accordance with
regulations of the veterinary office of the canton Zurich. Peripheral blood
was obtained by cardiac puncture and analysed on an ADVIA 2120
automated hemocytometer (Siemens Healthcare Diagnostics, Germany).
One hind leg (femur and tibia) and spleen were isolated. Single cell
suspensions were prepared by either flushing out bone marrow cells using
FACS buffer (PBS containing 2% FCS and 2.5 mM EDTA) or by gently
dissociating spleens between two frosted glass slides, followed by red blood
cell lysis using ammonium chloride solution. For flow cytometric analysis
of major myeloid and lymphoid compartments, cells were incubated with
fluorescent dye-labeled monoclonal antibodies (see supplementary material
Table S3) for 25 minutes on ice in the dark. After repeated wash steps, cells
were resuspended in FACS buffer containing 2 μg/ml Hoechst33324
(Invitrogen, USA) to exclude dead cells. Samples were analysed on a FACS
Canto II flow cytometer (Becton Dickinson, USA) and the data analysed
using FlowJo software (TreeStar, USA). 
Polysome profiling
Cells were tamoxifen-induced using 100 nM 4-OHT for 8-10 days or
control-treated in parallel. Prior to collection, cells were treated with 50
μg/ml cycloheximide (CHX) for 30 minutes at 37°C unless otherwise
indicated. Cells were collected in polysome lysis buffer (20 mM Tris, 10
mM MgCl2, 100 mM NaCl, 0.4% NP-40, Roche Complete Protease
Inhibitor, 100 U/ml RNasin and 50 μg/ml CHX in CHX-treated samples),
incubated on ice for 20 minutes, and centrifuged at 8000 g for 10 minutes
to pellet cell fragments. Protein content of the lysate was determined (Bio-
Rad Protein Assay) and equal amounts of total protein were loaded onto
17.5-50% sucrose density gradients (20 mM Tris, 5 mM MgCl2, 100 mM
NaCl and 50 μg/ml CHX in CHX-treated samples) formed by a Gradient
Master (BioComp) and ultracentrifuged for 2.5 hours in an SW40Ti Rotor
(Beckman Coulter) at 35,000 rpm. Gradients were fractionated by a Piston
Gradient Fractionator (BioComp). Curves were plotted on the same X/Y
axis. Areas under the curve from disome to the end of the graph and
monosome alone were measured using ImageJ pixel area measurement
software.
Metabolic labelling to measure protein synthesis rates
On the day of metabolic labelling, cells were washed in pre-warmed 1×
PBS. After the wash, 4 ml pre-warmed methionine- and cysteine-free
medium were added and cells were incubated for 1 hour at 37°C. As a
negative control, CHX was added at a final concentration of 300 nM to one
plate each of Dohhflox/flox;Creneg., Dohhflox/flox;Crepos. or Dohhflox/flox;Crepos. +
4-OHT. Click-IT® AHA (Invitrogen) was added to 100 μM final
concentration and cells were further incubated for 2 hours at 37°C. Plates
were then chilled on ice, 3 ml of medium was removed and cells were
harvested using a cell scraper and transferred to microcentrifuge tubes. Cells
were washed three times in ice-cold 1× PBS and lysed in 25 μl ice-cold lysis
buffer in the presence of protease and phosphatase inhibitors. Samples were
sonicated and centrifuged. Then, 5 μl H2O and 50 μl 2× Click-IT® Reaction
Buffer, 5 μl Component C (CuSO4) and 5 μl fresh Click-IT® Reaction Buffer
Additive 1 were added and the samples incubated for 3 minutes at room
temperature. After addition of 10 μl Click-IT® Reaction Buffer Additive 2,
samples were incubated 20 minutes at room temperature. Proteins were
subsequently precipitated and pellets were air-dried for 15 minutes. Proteins
were re-solubilized in 25 μl 1× LDS NuPAGE loading buffer and incubated
for 10 minutes at 70°C. Proteins were separated on a NuPAGE Novex 4-
12% BisTris-Acrylamide gel and the TAMRA signal was detected and
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quantified using a Fujifilm Fluorescent Image Analyzer FLA-9000. The gel
was stained using SYPRO Ruby (Life Technologies) according to the
manufacturer’s instructions for detection and quantification of total protein
content.
Statistics
The statistical tests used in each analysis are stated in the corresponding
figure legends. Statistical analyses were performed using GraphPad Prism
(GraphPad Software Inc, San Diego, CA). P-values are depicted using
asterisks, with *P<0.05, **P<0.01 and ***P<0.001. Error bars in all figures
represent the s.e.m. or s.d.
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